Implication of protocadherin-PC in the progression of the advanced prostate cancer
Giannakopoulos, X.; Stagikas, D.; Peschos, D.; Batistatou, A.; Charalabopoulos, K.
Experimental Oncology 29(1): 74-75
2007
ISSN/ISBN: 1812-9269 PMID: 17500101 Document Number: 612721
Document emailed within 1 workday
Related Documents
Vacherot, F.; Terry, Séphane.; Faucon, H.; Queires, L.; Chen, M-Wei.; Yang, X.; Gil Diez de Medina, S.; Verdier, A.; Azoulay, S.; Allory, Y.; Abbou, C.C.; Buttyan, R.; de la Taille, A. 2005: Protocadherin-PC discovery and its implication in prostate cancer progression Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 15(6 Suppl. 1): 1294-1302Murray, N.P.; Aedo, S.óc.; Fuentealba, C.; Reyes, E.; Minzer, S.; Salazar, A.íb. 2019: Circulating prostate cells and bone marrow micrometastasis are determinant in risk and time to biochemical progression in localized prostate cancer Archivos Espanoles de Urologia 72(5): 471-482
Harada, M. 2002: Histological classification of prostate cancer with clinicopathological implication Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 11): 76-81
Kelly, W.K.; Slovin, S.; Scher, H.I. 1996: Clinical use of posttherapy prostate-specific antigen changes in advanced prostate cancer Seminars in Oncology 23(6 Suppl 14: 8-14
Chen, H.-J.; Wang, H.; Zhang, L.; Zhang, Y.-K.; Wang, G.-M. 2006: Correlation between integrin subunits alpha5 and beta1 expressions in prostate cancer and its clinical implication Zhonghua Nan Ke Xue 12(2): 148-150
Mocarska, A.; Czarnocki, K.; Starosławska, E.; Janczarek, M.; Zelazowska-Cieslińska, I.; Losicki, M.; Burdan, F. 2014: Evaluation of prostate cancer progression Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 37(222): 356-364
Newling, D.W. 1990: Parameters of response and progression in prostate cancer Progress in Clinical and Biological Research 359: 25-48; Discussion: 73-74
Stromberg, J.S.; Martinez, A.A.; Horwitz, E.M.; Gustafson, G.S.; Gonzalez, J.A.; Spencer, W.F.; Brabbins, D.S.; Dmuchowski, C.F.; Hollander, J.B.; Vicini, F.A. 1997: Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatment Cancer Journal from Scientific American 3(6): 346-352
Teishima, J.; Matsubara, A. 2016: Mechanism of development and progression in prostate cancer: Overview Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 3): 80-86
Kanoh, Y.; Mashiko, T.; Danbara, M.; Takayama, Y.; Ohtani, S.; Egawa, S.; Baba, S.; Akahoshi, T. 2004: Changes in serum IgG oligosaccharide chains with prostate cancer progression Anticancer Research 24(5b): 3135-3139
Feng, W.; Zhang, H.-b.; Wang, Y.-m.; Hu, J.-l. 2015: Correlation of FOXA1 with the malignancy and progression of prostate cancer Zhonghua Nan Ke Xue 21(5): 414-419
Jenster, G. 1999: The role of the androgen receptor in the development and progression of prostate cancer Seminars in Oncology 26(4): 407-421
Shimazaki, J. 1998: Development and progression of prostate cancer in relation with androgen dependency Nihon Rinsho. Japanese Journal of Clinical Medicine 56(8): 1953-1958
Parsons, J.K.; Marshall, J.R.; Nelson, H. 2013: Does altering diet affect progression of prostate cancer? the MEAL study Bulletin of the American College of Surgeons 98(10): 57-59
Small, E.J.; Dawson, N.A.; Kantoff, P.W.; Vogelzang, N.J. 1996: Cancer and Leukemia Group B trials for advanced prostate cancer Seminars in Oncology 23(6 Suppl 14: 28-31
Feng, R.; Zhang, X.; Yang, S. 2016: Research status quo and progression in targeted therapy for advanced gastric cancer Zhonghua Wei Chang Wai Ke Za Zhi 19(10): 1191-1196
Spanjol, J.; Maricić, A.; Valencić, M.; Oguić, R.; Krpina, K.; Protić, A.; Ivancić, A.; Bobinac, M.; Fuckar, D.; Vojniković, B. 2008: Influence of insolation on osteoporosis progression in androgen deprived nonmetastatic prostate cancer patients Collegium Antropologicum 32(Suppl 2): 79-81
Lokeshwar, V.B.; Lokeshwar, B.L.; Pham, H.T.; Block, N.L. 1996: Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression Cancer Research 56(3): 651-657
Yamada, Y.; Fujiwara, H.; Somiya, S.; Fujikawa, S.; Kamiyama, Y.; Tamaki, M.; Kanaoka, T. 2018: Delay in High-Grade Metastatic Prostate Cancer Progression by Dutasteride : A Case Report Hinyokika Kiyo. Acta Urologica Japonica 64(4): 187-192
Orovan, W.L. 1989: Treatment of advanced cancer of the prostate Canadian Journal of Surgery. Journal Canadien de Chirurgie 32(5): 315-316